Bedaquiline (Sirturo®) recommended as an option for use within NHS Wales

An option for use as part of combination regimen for pulmonary multidrug-resistant TB in adults and adolescent patients (12 years to <18 years of age & weighing ≥30 kg) when an effective treatment regimen cannot otherwise be composed for reasons of resistance/tolerability.

All Wales Medicines Strategy Group